Bajaj Healthcare Completes Equity Share Allotment Following Warrant Conversion

Bajaj Healthcare Limited has successfully completed the allotment of 20,79,409 equity shares following the conversion of convertible warrants by 8 investors. The board meeting held on March 18, 2026, approved the allotment at an issue price of ₹338 per share, including a premium of ₹333 per share.

Board Meeting Outcome

The board of directors, in their meeting held on March 18, 2026, considered and approved the allotment of fully paid-up equity shares to promoter, promoter group, and non-promoter public category investors. The meeting commenced at 4:33 PM and concluded at 5:05 PM, with the outcome communicated to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI LODR Regulations.

Parameter: Details Meeting Date: March 18, 2026 Total Shares Allotted: 20,79,409 Issue Price: ₹338 per share Face Value: ₹5 per share Premium: ₹333 per share

Investor-wise Allotment Details

The warrant conversion involved 8 investors across different categories, with Swastik Capital being the largest beneficiary. All warrant holders exercised their conversion option and paid the balance 75% consideration amount.

Investor: Category Shares Allotted Consideration Amount (₹) Swastik Capital: Non-Promoter Public 7,82,574 19,83,82,509 Mr. Sajankumar Rameshwarlal Bajaj: Promoter 4,55,074 11,53,61,259 Mr. Anil Champalal Jain: Promoter Group 4,55,074 11,53,61,259 Dr. Ashish Garg: Non-Promoter Public 1,77,515 4,50,00,052.50 Mr. Mohit Poddaar: Non-Promoter Public 59,172 1,50,00,102 BH Lakhani: Non-Promoter Public 50,000 1,26,75,000 U.K Vora: Non-Promoter Public 50,000 1,26,75,000 Vimal Trading: Non-Promoter Public 50,000 1,26,75,000

Capital Structure Impact

Following the allotment, the company's issued, subscribed and paid-up equity share capital has increased significantly. The newly allotted equity shares rank pari-passu with existing shares in all respects, including dividend rights.

Capital Structure: Before Allotment After Allotment Paid-up Capital: ₹15,79,16,260 ₹16,83,13,305 Number of Shares: 3,15,83,252 3,36,62,661 Face Value per Share: ₹5 ₹5

Regulatory Compliance

The allotment was conducted in accordance with the special resolution passed by shareholders at the Extra-Ordinary General Meeting held on August 07, 2024, and complies with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The original warrants were allotted on September 19, 2024, with an 18-month conversion period. With this allotment, no warrants remain outstanding for conversion.

Bajaj Healthcare Limited has received a disclosure from promoter group member Anil Champalal Jain regarding the acquisition of 7,600 equity shares through open market purchase. The transaction, completed on March 16, 2026, was formally disclosed on March 17, 2026, in compliance with SEBI regulations.

Transaction Details

Anil Champalal Jain, who serves as Managing Director and is a member of the promoter group, acquired the shares through open market purchase. The acquisition represents a marginal increase in his shareholding in the pharmaceutical company.

Parameter: Details Shares Acquired: 7,600 equity shares Acquisition Date: March 16, 2026 Acquisition Mode: Open Market Purchase Disclosure Date: March 17, 2026 Acquirer Status: Promoter Group Member

Shareholding Pattern Changes

The acquisition resulted in a slight increase in Jain's overall shareholding in Bajaj Healthcare Limited. His total holding now includes both equity shares and warrants/convertible securities.

Holding Category: Before Acquisition After Acquisition Change Equity Shares: 14,66,775 14,74,375 +7,600 Warrants/Convertible Securities: 4,55,074 4,55,074 No change Total Holdings: 19,21,849 19,29,449 +7,600 Percentage of Share Capital: 6.08% 6.11% +0.03% Percentage of Diluted Capital: 5.71% 5.73% +0.02%

Company Capital Structure

Bajaj Healthcare Limited's equity share capital remains unchanged following this transaction. The company maintains its existing capital structure with no impact from this promoter group acquisition.

Capital Details: Amount Total Equity Shares: 3,15,83,252 shares Face Value per Share: ₹5 Total Share Capital: ₹15,79,16,260 Diluted Share Capital: ₹16,83,13,305 Total Diluted Shares: 3,36,62,661 shares

Regulatory Compliance

The disclosure was made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited. The formal disclosure document was digitally signed and submitted to comply with regulatory filing requirements.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.